| Q30370100 | A "Wear and Tear" Hypothesis to Explain Sudden Infant Death Syndrome. |
| Q37051945 | Acceptability of neonatal circumcision by Hispanics in southern Florida |
| Q37348083 | Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. |
| Q33993731 | Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine |
| Q34572271 | Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men |
| Q37220744 | Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. |
| Q24648641 | Can routine neonatal circumcision help prevent human immunodeficiency virus transmission in the United States? |
| Q49579785 | Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version). |
| Q37835559 | Circumcision Status is Not Associated with Condom Use and Prevalence of Sexually Transmitted Infections Among Young Black MSM. |
| Q37000894 | Circumcision and human papillomavirus infection in men: a site-specific comparison |
| Q37442441 | Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia |
| Q36037214 | Circumcision and the risk of prostate cancer |
| Q47788706 | Circumcision of preschool boys in Baghdad, Iraq: prevalence, current practice and complications |
| Q42116089 | Commentary: male circumcision for prevention of heterosexual acquisition of HIV in men: perspective from a trial team |
| Q21562586 | Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males |
| Q24630822 | Costs and effectiveness of neonatal male circumcision |
| Q24657711 | Determinants and policy implications of male circumcision in the United States |
| Q37246235 | Does Routine Pathology Analysis of Adult Circumcision Tissue Identify Penile Cancer? |
| Q34205575 | Ending the epidemic of heterosexual HIV transmission among African Americans |
| Q37693170 | Exposé of misleading claims that male circumcision will increase HIV infections in Africa |
| Q36157198 | Factors associated with acceptability of child circumcision in Botswana -- a cross sectional survey |
| Q37363834 | Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention |
| Q37693125 | How the circumcision solution in Africa will increase HIV infections |
| Q37556446 | Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population |
| Q34104917 | Making the case for circumcision as a public health strategy: opening the dialogue |
| Q34078337 | Male Circumcision Rates in Patients From a Sexually Transmitted Disease Clinic in Southern Florida and Acceptability of Circumcision Among Hispanics |
| Q44752072 | Male circumcision and HPV transmission to female partners |
| Q34225858 | Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa |
| Q31120761 | Male circumcision for prevention of HIV transmission: what the new data mean for HIV prevention in the United States |
| Q24236267 | Male circumcision for prevention of homosexual acquisition of HIV in men |
| Q37178782 | Male circumcision for the prevention of HSV-2 and HPV infections and syphilis |
| Q34010053 | Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision |
| Q37458308 | Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation |
| Q28300040 | Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections |
| Q33696533 | Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States |
| Q36988825 | Penile cancer disparities in Puerto Rican men as compared to the United States population |
| Q33538879 | Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India |
| Q34343570 | Prenatal and perinatal analgesic exposure and autism: an ecological link |
| Q24621538 | Review: a critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries |
| Q43149733 | Risk Factors and Prevalence of Penile Cancer |
| Q34089682 | Risk factors for HIV-1 seroconversion among Taiwanese men visiting gay saunas who have sex with men. |
| Q39624478 | Risk factors for HIV/syphilis infection and male circumcision practices and preferences among men who have sex with men in China. |
| Q36844804 | Sexually transmitted infections and male circumcision: a systematic review and meta-analysis |
| Q34995565 | SmartClamp circumcision versus conventional dissection technique in terms of parental anxiety and outcomes: A prospective clinical study. |
| Q34310914 | The Prevalence of HIV by Ethnic Group Is Correlated with HSV-2 and Syphilis Prevalence in Kenya, South Africa, the United Kingdom, and the United States |
| Q36355708 | The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding |
| Q34057360 | Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences |
| Q45381815 | What is the potential impact of adult circumcision on the HIV epidemic among men who have sex with men in San Francisco? |
| Q28473150 | Willingness of men who have sex with men (MSM) in the United States to be circumcised as adults to reduce the risk of HIV infection |